Company Filing History:
2 out of 575 
2 out of 1,997 
1 out of 1 
Years Active: 1989-2020
Title: Richard Rubenstein: Innovator in Traumatic Injury Biomarkers
Introduction
Richard Rubenstein is a notable inventor based in Staten Island, NY (US). He has made significant contributions to the field of biomedical research, particularly in the area of traumatic injuries of the central nervous system. With a total of 5 patents to his name, Rubenstein's work focuses on the development of protein biomarkers that can aid in the assessment and monitoring of CNS injuries.
Latest Patents
Rubenstein's latest patents include groundbreaking research on protein biomarkers for acute, subacute, and chronic traumatic injuries of the central nervous system. These patents describe proteins that are differentially expressed or elevated in tissue and biofluids following CNS injuries. The elevated or reduced levels of these proteins can be utilized to assess the severity of CNS injuries, including traumatic brain injury (TBI), traumatic spinal cord injury (SCI), and chronic traumatic encephalopathy (CTE). Furthermore, time course measurements of these proteins post-CNS injury can be instrumental in monitoring recovery over several months. Another significant patent involves an ultrasensitive assay for tau, which provides methods for accurately quantifying T-tau and P-tau in tissues and biofluids, thereby enhancing the assessment of traumatic brain injury.
Career Highlights
Throughout his career, Richard Rubenstein has worked with esteemed organizations such as Los Alamos National Security, LLC and the State University of New York. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to innovative research.
Collaborations
Rubenstein has collaborated with notable colleagues, including Martin S Piltch and Perry Clayton Gray. These partnerships have further enriched his research and development efforts in the realm of traumatic injury biomarkers.
Conclusion
Richard Rubenstein's contributions to the field of traumatic injury biomarkers are invaluable. His innovative patents and collaborations highlight his commitment to advancing medical research and improving patient outcomes.